NEW YORK (GenomeWeb News) – Software maker Temis said today that Laboratoires Fournier, a drug discovery affiliate of Solvay Pharmaceuticals, will use Temis’ Luxid text analytic solution.
 
Laboratoires Fournier will use the software in its Exploratory Biology Unit, which searches for biomarkers that could be used in Solvay’s pre-clinical drug development programs.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.